TK

Themasap Khan

Co-Founder & Partner @ Luma Group

New York City Metropolitan Area

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Molecular Biology
Microsoft Office
Biotechnology
PCR
Research
Microsoft Excel
PowerPoint
Cell Culture
Microsoft Word
Matlab
Lifesciences
Biochemistry
Neuroscience
Data Analysis
Life Sciences
Public Speaking
Social Media
Microsoft PowerPoint

Education

Lists including Themasap

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

LG
Luma Group

2023

  • Partner & Co-Founder

    2023

CV
Civilization Ventures

2018

  • Senior Advisor

    2023

    Worked to identify, diligence, invest in and grow companies such as Rewrite Therapeutic, Foresight Diagnostics, Replace Therapeutics, Outpace Bio, BillionToOne, Tacit Therapeutics and several others.

  • Vice President

    2021 - 2022

  • Founding Associate

    2018 - 2020